Found: 16
Select item for more details and to access through your institution.
The interaction of platinum-based drugs with native biologically relevant proteins.
- Published in:
- Analytical & Bioanalytical Chemistry, 2013, v. 405, n. 6, p. 1855, doi. 10.1007/s00216-012-6410-z
- By:
- Publication type:
- Article
Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0142612
- By:
- Publication type:
- Article
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Association of telomerase activity with radio- and chemosensitivity of neuroblastomas.
- Published in:
- Radiation Oncology, 2010, v. 5, p. 66, doi. 10.1186/1748-717X-5-66
- By:
- Publication type:
- Article
Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 8, p. 1787, doi. 10.1002/ijc.22401
- By:
- Publication type:
- Article
INITIAL FINDINGS FROM A RETROSPECTIVE STUDY OF AUDIOLOGICAL THRESHOLDS IN CHILDREN WITH CRANIAL RADIOTHERAPY IN COMBINATION WITH PLATIN-BASED CHEMOTHERAPY.
- Published in:
- Journal of International Advanced Otology, 2015, v. 11, p. 38
- By:
- Publication type:
- Article
Asparaginase pharmacology: challenges still to be faced.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 3, p. 647, doi. 10.1007/s00280-010-1361-6
- By:
- Publication type:
- Article
Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-78549-y
- By:
- Publication type:
- Article
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75662-w
- By:
- Publication type:
- Article
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure.
- Published in:
- BMC Pharmacology & Toxicology, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s40360-020-00417-2
- By:
- Publication type:
- Article
A population pharmacokinetic model for pegylated-asparaginase in children.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 1, p. 119, doi. 10.1111/j.1365-2141.2009.07923.x
- By:
- Publication type:
- Article
No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 258, doi. 10.1002/pbc.24292
- By:
- Publication type:
- Article
Five-year single-center study of asparaginase therapy within the ALL-BFM 2000 trial.
- Published in:
- Pediatric Blood & Cancer, 2011, v. 57, n. 3, p. 378, doi. 10.1002/pbc.23041
- By:
- Publication type:
- Article
Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 54, n. 7, p. 952, doi. 10.1002/pbc.22417
- By:
- Publication type:
- Article